Cargando…

Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles

About 5% of Triple negative breast cancer patients (TNBCs) who receive neoadjuvant chemotherapy (NAC) experience progressive disease (PD). Few reports are published on TNBCs with PD during NAC, whereas TNBCs that respond to NAC have been well-studied. We investigated kinase activity profiles of TNBC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawada, Takeshi, Hilhorst, Riet, Rangarajan, Savithri, Yoshida, Masayuki, Tanabe, Yuko, Tamura, Kenji, Kinoshita, Takayuki, Shimoyama, Tatsu, van Beuningen, Rinie, Ruijtenbeek, Rob, Tsuda, Hitoshi, Koizumi, Fumiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188135/ https://www.ncbi.nlm.nih.gov/pubmed/30344939 http://dx.doi.org/10.18632/oncotarget.26026

Ejemplares similares

Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy
por: Tanabe, Yuko, et al.
Publicado: (2017)

Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cells
por: Sawada, Takeshi, et al.
Publicado: (2016)

Long-term complete remission in a patient with intravascular large B-cell lymphoma with central nervous system involvement
por: Sawada, Takeshi, et al.
Publicado: (2014)

Analysis of Jak2 Catalytic Function by Peptide Microarrays: The Role of the JH2 Domain and V617F Mutation
por: Sanz, Arturo, et al.
Publicado: (2011)

Drug-induced aneuploidy and polyploidy is a mechanism of disease relapse in MYC/BCL2-addicted diffuse large B-cell lymphoma
por: Islam, Shariful, et al.
Publicado: (2018)

Phase I, pharmacokinetic, and biological studies of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, administered after meals with solid tumors
por: Murakami, Haruyasu, et al.
Publicado: (2010)

Phase I and pharmacokinetic study of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, by twice daily oral administration between meals in patients with advanced solid tumors
por: Ueda, Yutaka, et al.
Publicado: (2010)

Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3
por: Kodera, Yasuo, et al.
Publicado: (2011)

Differentiating Benign from Malignant Thyroid Tumors by Kinase Activity Profiling and Dabrafenib BRAF V600E Targeting
por: Hilhorst, Riet, et al.
Publicado: (2023)

Transcriptomic profiling of single circulating tumor cells provides insight into human metastatic gastric cancer
por: Negishi, Ryo, et al.
Publicado: (2022)

Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer
por: Sawada, Takeshi, et al.
Publicado: (2016)

Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ
por: Tamura, Nobuko, et al.
Publicado: (2015)

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
por: Tanioka, M, et al.
Publicado: (2010)

Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma
por: Sugano, Teppei, et al.
Publicado: (2020)

Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers 2020, 12, 512
por: Krayem, Mohammad, et al.
Publicado: (2020)

Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma
por: Krayem, Mohamad, et al.
Publicado: (2020)

MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic
por: Kageyama, Akihiko, et al.
Publicado: (2021)

Impact of pegfilgrastim approval on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma
por: Morita, Yuka, et al.
Publicado: (2022)

Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study
por: Yagi, Yu, et al.
Publicado: (2022)

Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the Literature
por: Funasaka, Chikako, et al.
Publicado: (2019)

Neoadjuvant chemotherapy in oral cancers: Selecting the right patients
por: Vishak, S., et al.
Publicado: (2015)

Identification of Novel Substrates for cGMP Dependent Protein Kinase (PKG) through Kinase Activity Profiling to Understand Its Putative Role in Inherited Retinal Degeneration
por: Roy, Akanksha, et al.
Publicado: (2021)

Differential in Vitro Biological Action, Coregulator Interactions, and Molecular Dynamic Analysis of Bisphenol A (BPA), BPAF, and BPS Ligand–ER [Formula: see text] Complexes
por: Li, Yin, et al.
Publicado: (2018)

Assessment of physical inactivity and locomotor dysfunction in adults with visual impairment
por: Inoue, Sachiko, et al.
Publicado: (2018)

Positioning X for inactivity
por: Williams, Ruth
Publicado: (2007)

PEMPHIGUS: ACTIVE OR INACTIVE?
por: Vaishnani, Jignesh B, et al.
Publicado: (2009)

Actively tackling inactivity
por: Haake, Steve, et al.
Publicado: (2022)

P1153: UTILITY OF THE FRAILTY SCORE FOR PREDICTING PROGNOSIS AND INDIVIDUALIZING TREATMENT INTENSITY IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
por: Yagi, Yu, et al.
Publicado: (2023)

Estimating the molecular evolutionary rates of mitochondrial genes referring to Quaternary ice age events with inferred population expansions and dispersals in Japanese Apodemus
por: Suzuki, Yutaro, et al.
Publicado: (2015)

Kinase activity profiling identifies putative downstream targets of cGMP/PKG signaling in inherited retinal neurodegeneration
por: Roy, Akanksha, et al.
Publicado: (2022)

The Kiss Switch Brings Inactive R3C Ligase Ribozyme Back to Life
por: Tanizawa, Kana, et al.
Publicado: (2018)

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
por: Dhumal, Sachin, et al.
Publicado: (2019)

Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report
por: Uematsu, Mao, et al.
Publicado: (2019)

Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis
por: van der Wel, Tom, et al.
Publicado: (2020)

AN INACTIVE PRECURSOR OF STREPTOCOCCAL PROTEINASE
por: Elliott, Stuart D., et al.
Publicado: (1947)

Physical Inactivity and Mortality Risk
por: Kokkinos, Peter, et al.
Publicado: (2011)

Physical inactivity in Parkinson’s disease
por: van Nimwegen, Marlies, et al.
Publicado: (2011)

Characterization of inactive carbon in GaAs
por: Moll, A J, et al.
Publicado: (1994)

Catalytically inactive telomerase in oncogenesis
por: Tergaonkar, Vinay
Publicado: (2015)

Physical Inactivity in Pulmonary Sarcoidosis
por: Cho, Peter S. P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tk0osd43euqv08gcc51283db2i